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ABSTRACT
Objective:The purpose ofthis study was to determine whether an enrichmentmethod would improve
the performance of an enzyme immunoassay test, the ICON Strep B, for detection of group B
streptococci (GBS) in vaginoperineal swabs.
Methods: The study was done in 3 phases. First, in 250 maternity patients, 2 swabs per patient
were tested simultaneously by an overnight selective broth culture method (Lim broth) and the
ICON assay. Forty-five (18%) specimens were positive for GBS by culture. The ICON assay
detected only 2 (4%) of the positives. Second, in 391 maternity patients, a single swab was cultured
as above. However, during the overnight incubation ofthe Lim broth, 0.5 ml aliquots were removed
and tested by ICON assay at 4, 6, 8, 10, and 12 h post-incubation. Seventy-two specimens (18%)
were positive by culture. The ICON assay detected 20% of the positives at 4 h, 46% at 6 h, 70%
at 8 h, 94% at 10 h, and 100% at 12 h post-incubation. Third, 97 high-risk patients with the diagnosis
ofpreterm labor (PTL)/or preterm premature rupture of the membranes (PPROM) were sampled.
Three specimens per patient were obtained: a single swab that was cultured as before and 2 double
swabs, of which 1 was tested directly using the ICON test and the other was placed directly in
Lim broth and incubated overnight. The aliquots of broth were tested by the ICON assay at 2, 4,
6, and 8 h post-incubation. Twenty-four specimens were positive by culture.
Results: The direct ICON test detected only 4 (17%) of the positives. The ICON assay performed
on the enriched samples detected 4% of the positives at 2 h, 21% at 4 h, 58% at 6 h, and 100% at
8 h post-incubation.
Conclusions: These data indicate that the ICON assay may be used with 100% sensitivity and
specificity to detect GBS-colonized high-risk mothers within 8 h if the initial sample size is doubled
and the enrichment broth is used in the performance of the ICON assay. (C) 1996 Wiley-Liss, Inc.
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aginal colonization with group B streptococci
(GBS) occurs in 10-30% of normal pregnancies,
while neonatal colonization occurs in 40-70% of the
infants born to colonized women. Approximately
1-2% of colonized infants ultimately develop early
onset neonatal GBS sepsis, a disease with a high
mortality rate (22-29%) and much morbidity.
3-5 Up
to 15,000 cases of neonatal sepsis each year are
caused by GBS. The factors that increase the risk
for the development of GBS sepsis include low
birth weight and prematurity, prolonged membrane
rupture, and maternal factors such as fever in labor
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and heavy vaginal colonization. In 1986, Boyer and
Gotoff and Morales et al. demonstrated that intra-
partum ampicillin prophylaxis in mothers colonized
with GBS during the third trimester resulted in a
decrease in neonatal colonization and neonatal GBS
disease. Recognizing those patients who would
most benefit from intrapartum ampicillin prophy-
laxis, however, remains a major problem. Boyer et
al. and Allardice et al.1 have demonstrated that
antepartum cultures may not be predictive of intra-
partum colonization status, because ohly 55-67%
of women with positive cultures during the third
trimester will have positive cultures at the time of
delivery, even in the absence of treatment with
antibiotics. In addition, approximately 5-10% of the
women with negative antepartum cultures will have
positive cultures when they are evaluated intrapar-
turn.9’1 It is evident that there is a great need for
rapid and accurate detection of GBS, especially in
those patients whose infants are at high risk for
neonatal GBS disease.
The available commercial rapid tests for GBS
have sensitivities ranging from 11 to 30% compared
with cultures on selective medium.’-13The current
study was undertaken to explore the possibility of
using an enrichment broth (to increase the bacterial
load) prior to testing the specimen with a rapid
assay (ICON) in order to increase the sensitivity of
the rapid test and shorten the time for a diagnosis.
MATERIALS AND METHODS
Patient Population
During the first phase of the study, from October
1992 to March 1993, 250 maternity patients pres-
enting at Children’s Hospital of Buffalo for evalua-
tion of labor or possible rupture of the membranes
were enrolled. For the second phase of the study,
from July 1993 to February 1994, 391 maternity
patients from the same population were enrolled.
During the third phase of the study, from April 1994
to April 1995, 97 women admitted to the Children’s
Hospital with the diagnosis of preterm (<37 weeks
gestation) labor (PTL) or preterm premature rup-
ture of the membranes (PPROM) were enrolled.
Specimen Processing and Culture Method
Phase One
For the first phase ofthe study, the 2 vaginoperineal
swabs were collected in culturettes containing a
rayon-tipped swab and an ampule of modified Stu-
art’s medium (Becton Dickinson, Cockeysville,
MD). The first swab with an intact ampule was
tested by the ICON assay (Hybritech, Inc., San
Diego, CA). Within 4 h from the time of collection,
the second swab was plated semiquantitatively on
5% sheep blood agar (BA). The swab then was
placed in Lim broth (Todd-Hewitt broth containing
1% yeast extract, 10 txg/ml of colistin, and 15
ml of nalidixic acid), a selective enrichment broth.
The BA and the Lim broth were incubated in 5%
COz and air, respectively, at 36C overnight. The
Lim broth was subcultured onto a BA plate the
following day.
Phase Two
During the second phase of the study, 1 vaginoperi-
neal swab was collected per patient using single-
swab culturettes. The specimen was cultured as
above except that, during the incubation, 0.5 ml
aliquots of the Lim broth were removed at 4, 6, 8,
10, and 12 h post-incubation and frozen at -20C
until needed for ICON testing. The frozen samples
were batched and tested once a week. The re-
maining Lim broth was subcultured to a BA plate
at 24 h post-incubation. All media were obtained
from BBL (Becton Dickinson). The confirmation
of GBS from the cultures was acomplished with
one of the following agglutination kits: Streptococci
grouping kit (Becton Dickinson) or Streptex (Mu-
rex, Diagnostics Limited, Dartford, England).
Phase Three
In order to increase the initial bacterial load in the
specimens, we obtained 3 specimens per patient:
single-swab culturette that was cultured as in
phase one using BA and 24-h Lim broth; double-
swab culturette that was tested directly with the
ICON assay; and double-swab culturette that was
placed directly into Lira broth and incubated over-
night. The aliquots of this Lim broth tube were
removed at 2, 4, 6, and 8 h post-incubation and
handled as in phase two.
ICON Assay
Specimen Handling
To determine the best way by which to process
the Lim broth specimens for testing by ICON, we
conducted a preliminary study. Fifty known posi-
tive (by culture) and 7 known negative Lim broth
samples from clinical specimens were tested. Each
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TABLE I. Sensitivity, specificity, and predictive value of direct ICON rapid GBS detection kit in comparison
with selective GBS culture
Maternity patients PPROM or PTL Heavily colonized
(N 250) (N 97) (N-- 30)
Sensitivity (%) 6 17 20
Specificity (%) 100 97 97
PPV (%) 100 67 86
NPV (%) 83 78 61
aPPV, positive predictive value; NPV, negative predictive value.
bThe ICON assay was performed using a single-swab culturette.
CThe ICON assay was performed using a double-swab culturette.
dThe data were analyzed considering only those patients with heavy colonization (patients with ->2+ colonies on the initial BA plate) as positive (30
positives/69 total patients).
sample was divided in 4 1-ml aliquots. The first
aliquot was centrifuged for 15 min at 1,500 g, after
which the pellet was picked up with a swab (pro-
vided with the ICON kit) and tested by the ICON
assay. The second and third aliquots were processed
as boiled and unboiled urine specimens following
the manufacturer’s protocol. A swab (provided with
the ICON kit) was placed in the fourth aliquot
until it was saturated and then tested following
the manufacturer’s instructions. The results were
analyzed and factors such as the amount of labor
involved, ease of interpretation (little or no back-
ground), sensitivity, and specificity were considered
in determining the best way to test the Lira broth
by the ICON assay. The results (not shown here)
indicated that the best way to test Lim broth for
GBS was to saturate a swab with the broth and
to test the saturated swab with the ICON assay
following the manufacturer’s instruction.
RESULTS
Phase One
Forty-five (18%) patients were culture positive for
GBS. Of these, 29 (64%) had +, 7 (16%) had 2+,
and 9 (20%) had 3+ to 4+ colonies. Table depicts
the value of the ICON assay. As seen, the sensitivity
varied from 6 to 20%. In contrast, the specificity of
the assay was high at 97-100%. These data suggest
that the ICON assay is not valuable as a test per-
formed directly on the initial specimen.
Phase Two
Seventy-two (18%) patients were culture positive
for GBS. Of these, 39 (54%) had +, 14 (19%) had
2+, and 19 (26%) had 3+ to 4+ colonies. The
ICON assay performed on aliquots of the enrich-
ment broth detected 20% at 4 h, 46% at 6 h, 70% at
8 h, 94% at 10 h, and 100% at 12 h post-enrichment.
These data suggest that the ICON shortened the
time required for a diagnosis from 48 h by culture
to 12h.
Phase Three
Twenty-four (25%) patients were culture positive.
Of these, 11 (46%) had +, 9 (38%) had 2+, and
4 (17%) had 3+ to 4+ colonies. The direct ICON
assay detected only 4 positive patients, all ofwhom
had 3+ or 4+ colony counts. As shown in Table 1,
when the ICON assay was used to test only the
patients with PTL and PPROM, the sensitivity of
the direct ICON test improved compared with the
ICON assay used to test a mixed maternity popula-
tion (phase-one patients). However, the specificity
of the ICON assay decreased. The direct ICON
test was positive in 2 patients with negative cul-
tures. The culture grew only yeast and lactobacilli
in patient and coagulase-negative staphylococci,
enterococci, lactobacilli, and yeast in the other pa-
tient. The ICON assay performed on aliquots of
the enrichment broth detected 4% of the positives
at 2 h, 21% at 4 h, 58% at 6 h, and 100% at 8 h
post-enrichment. As illustrated in Tables 1 and 2,
if the ICON assay is used in high-risk populations
and if the initial inoculum size is doubled by using
double-swabbed culturettes, the sensitivity will in-
crease 3-fold (6% vs. 17%). At 8 h post-enrichment,
the sensitivity will reach 100%.
Prior studies of rapid GBS detection systems
have shown improved sensitivity only with regard to
those patients with heavy vaginal colonization. 1’11-9
Therefore, we analyzed the ICON results from
heavily colonized patients in phases one and three,
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TABLE 2. Effects of patient population and initial inoculum size on sensitivity of ICON assay performed on
specimens enriched over time
Time post-enrichment (h)
Sensitivity of ICON assay (%)
Maternity patients
(N 391)
PPROM or PTL patients
(N 97)
2 NP 4
4 20 21
6 46 58
8 70 100
10 94 NP
12 100 NP
aNP, not performed.
bThe ICON assay was performed using a single-swab culturette.
CThe ICON assay was performed using a double-swab culturette.
defining >-2+ on the initial BA plate as positive
(N 69). As shown in Table 1, the sensitivity of
the ICON assay also improved in our study. The
false-negative rate or the percentage of carriers not
identified by a rapid assay increases with decreasing
colony counts (the lighter the colonization, the
greater the false-negative rate). Among patients in
phases one and three of the study, only 3% of those
with 1+ colonies and 43% of those with 3+ and
4+ colonies were detected by the ICON assay.
DISCUSSION
Although the first studies to use the ICON assay
for the rapid detection ofGBS reported higher sen-
sitivities (92% by Park et al.z and 33% by Gentry
et a1.16), these results have been criticized for com-
paring the rapid test with culture results obtained
with nonselective medium. A subsequent study of
the ICON test in comparison with selective culture
revealed a lower sensitivity (11% by Armer et a1.11).
Our finding that the sensitivity of the ICON assay
is low is in agreement with Armer et al. 11
The results with other rapid test methods have
proved equally disappointing. Using a different en-
zyme immunoassay (Equate (R) assay), Dinsmoor et
al. reported a sensitivity of 28%, Skoll et al. 15 15%,
and Greenspoon et al. 14 33%. All 3 authors con-
cluded that the assay is not sufficiently sensitive in
detecting light colonization, which would preclude
it from routine use in the clinical setting. Additional
studies using latex agglutination tests have resulted
in similar findings, with sensitivities ranging from
15 to 30% and specificities from 93 to 100% and
negative predictive values of76-88% in those popu-
lations with significant colonization rates. 1z-14,s,9,zl
Many studies (including the current study and
a previous study ofone ofthe authors 1) have demon-
strated an increased sensitivity of the rapid test
when it is used only in heavily colonized women.
It remains, however, a matter of discussion as to
whether or not the detection of only heavily colo-
nized mothers is adequate, l,z,z3 Isada and Gross-
man8 reported that all 9 cases of "clinically signifi-
cant" perinatal GBS morbidity were identified
using a rapid latex agglutination test in a population
with a low (4.4%) GBS prevalence. Although heavy
maternal colonization increases the risk for neonatal
GBS disease, many cases of GBS sepsis have been
reported in infants ofwomen who were only lightly
colonized.8,’zz-z4 Therapeutic levels of ampicillin
can be achieved in fetal serum within hours after
a single maternal dose. It has been the basis of
antibiotic chemoprophylaxis in a GBS carrier or a
patient with an unknown GBS status and PPROM.
A rapid antigen test for the detection of GBS in a
patient with an unknown carrier status would be of
tremendous clinical importance in identifying high-
risk patients and instituting chemoprophylaxis
against newborn and maternal postpartum sepsis.
If the diagnostic test takes longer than 12 h, chemo-
prophylaxis has to be maintained even in a patient
who is later found to be negative.
It is evident that, unless the sensitivity of direct
rapid GBS assays is improved to detect even light
colonization, their use in chemoprophylaxis proto-
cols is to be discouraged. If a "good" rapid test for
direct detection of GBS is one that can be per-
formed within 2 h of specimen collection with
>95% sensitivity, the direct ICON assay does not
seem to have a place in chemoprophylaxis protocols
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to identify patients at high risk for neonatal sepsis.
In our study, after determining the baseline sensi-
tivity of the ICON assay (phase one), we took 2
approaches to increase the sensitivity of the assay.
First, we utilized an enrichment broth method prior
to testing (phase two). In a mixed maternity popula-
tion, we were able to detect GBS in 94% and 100%
of the colonized patients 10 and 12 h post-enrich-
ment, respectively. Second, we increased the start-
ing inoculum size by sampling double swabs (phase
three). In a high-risk population, we were able to
detect GBS in 100% of the colonized patients 8 h
post-enrichment.
Our findings suggest that the double-swab and
enrichment technique may be used in conjunction
with the ICON assay to reliably replace the culture
method and shorten the diagnostic time from 48 h
to <12 h. This approach may be used to continue
antibiotic therapy in colonized patients, discontinue
therapy in noncolonized patients, or appropriately
treat at-risk patients.
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